We are live on ! Find out more
BMY icon

Bristol-Myers Squibb
BMY

1,179 hedge funds and large institutions have $49.8B invested in Bristol-Myers Squibb in 2013 Q2 according to their latest regulatory filings, with 1,179 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.53% more ownership

Funds ownership: 0% → 68.53% (+69%)

1% more call options, than puts

Call options by funds: $519M | Put options by funds: $516M

Holders
1,179
Holders Change
+1,179
Holders Change %
–
% of All Funds
38.47%
Holding in Top 10
49
Holding in Top 10 Change
+49
Holding in Top 10 Change %
% of All Funds
1.6%
New
1,179
Increased
–
Reduced
–
Closed
–
Calls
$519M
Puts
$516M
Net Calls
+$2.99M
Net Calls Change
+$2.99M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FCB
576
First Citizens Bancorporation
South Carolina
$1.99M +$1.93M +44,555 New
AI
577
ArchPoint Investors
Florida
$1.99M +$1.93M +44,450 New
NSIM
578
North Star Investment Management
Illinois
$1.96M +$1.9M +43,877 New
AB
579
Amalgamated Bank
New York
$1.96M +$1.91M +43,891 New
AF
580
Arrow Financial
New York
$1.94M +$1.89M +43,440 New
IT
581
Investors Trust
Texas
$1.92M +$1.87M +42,988 New
LNWWM
582
Laird Norton Wetherby Wealth Management
California
$1.92M +$1.86M +42,931 New
WSTAM
583
Wilbanks Smith & Thomas Asset Management
Virginia
$1.92M +$1.86M +42,916 New
IMOV
584
Investment Management of Virginia
Virginia
$1.89M +$1.84M +42,386 New
EB
585
Eastern Bank
Massachusetts
$1.88M +$1.83M +42,106 New
BIA
586
Biondo Investment Advisors
Pennsylvania
$1.88M +$1.82M +41,956 New
HDIM
587
Hanson & Doremus Investment Management
Vermont
$1.86M +$1.81M +41,663 New
FHC
588
First Horizon Corporation
Tennessee
$1.86M +$1.8M +41,521 New
ECM
589
Everence Capital Management
Indiana
$1.82M +$1.77M +40,707 New
AC
590
Alley Company
Illinois
$1.8M +$1.75M +40,212 New
TCOV
591
Trust Company of Vermont
Vermont
$1.79M +$1.74M +40,025 New
HCMNY
592
Howard Capital Management (New York)
New York
$1.78M +$1.73M +39,921 New
SBH
593
Segall Bryant & Hamill
Illinois
$1.77M +$1.72M +39,645 New
GG
594
Gofen & Glossberg
Illinois
$1.77M +$1.72M +39,627 New
AWA
595
AmeriServ Wealth Advisors
Pennsylvania
$1.77M +$1.72M +39,642 New
EOJOAM
596
E. Ohman J:or Asset Management
Sweden
$1.77M +$1.71M +39,500 New
TWA
597
TCI Wealth Advisors
Arizona
$1.76M +$1.71M +39,318 New
SC
598
Scotia Capital
Ontario, Canada
$1.75M +$1.71M +39,284 New
CONA
599
Capital One National Association
New York
$1.75M +$1.7M +39,090 New
FI
600
FCM Investments
Texas
$1.75M +$1.7M +39,060 New
22 23
24
25 26

BMY Hedge Fund Activity: Q2 2013 in Review

1,179 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2013, worth a combined $49.8B.

Buyers outnumbered sellers: 1,179 funds opened new BMY positions and 0 closed out — a net gain of 1,179 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,179 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $49.8B of Bristol-Myers Squibb stock for Q2 2013.
  • 1,179 funds opened new Bristol-Myers Squibb positions in Q2 2013 and 0 closed out, a net change of +1,179 holders.

Based on aggregated 13F filings for Q2 2013.